Awareness and Knowledge of Congenital Cytomegalovirus (cCMV) Among Audiologists and Speech-Language Pathologists in Saudi Arabia: A Cross Sectional Survey
Esraa Aldawood,Zainab Aldawood,Mohammad Alfhili
DOI: https://doi.org/10.2147/jmdh.s474581
2024-08-30
Journal of Multidisciplinary Healthcare
Abstract:Esraa Aldawood, 1 Zainab Aldawood, 2 Mohammad Alfhili 1 1 Department of Clinical Laboratory Science, College of Applied Medical Science, King Saud University, Riyadh, 11433, Kingdom of Saudi Arabia; 2 Family and Child Support Center, International Medical Center (IMC), Thuwal, 6900, Kingdom of Saudi Arabia Correspondence: Esraa Aldawood, Email Congenital cytomegalovirus (cCMV) is the most prevalent congenital infection in the world. It can result in various neurodevelopmental disorders, one of which is environmental hearing loss among children. This study aimed to assess the awareness and knowledge of cCMV among audiologists and speech-language pathologists (SLPs) in Saudi Arabia and to seek their perception of it. An online survey was conducted from May to June 2023, targeting participants through social media, and a descriptive and inferential analysis was performed. A total of 107 participants (31 audiologists and 76 SLPs) were enrolled in this study. Awareness about cCMV was significantly higher among audiologists (84%) compared to SLPs (49%) ( p -value < 0.001). However, both groups exhibited poor cCMV knowledge, which was revealed by their low mean knowledge scores (6.8/14 for audiologists and 5.7/14 for SLPs). The difference between their mean scores was non-significant ( p -value > 0.05). The majority of SLPs and audiologists agreed that it is crucial for them to learn more about cCMV to enrich their professional backgrounds. This study emphasized the necessity for cCMV education for audiologists and SLPs. Increased awareness and knowledge may allow them to be more mindful of cCMV symptoms and therefore provide enhanced service to their pediatric patients. Keywords: congenital cytomegalovirus, audiologist, speech-language pathologist, hearing loss, neurodevelopmental disorder Congenital cytomegalovirus (cCMV) is the most common congenital infection worldwide and a major cause of neurodevelopmental impairment in children. 1,2 CMV, a member of the human herpes virus family, is typically asymptomatic in immunocompetent individuals. However, nearly 10% of primary infections result in mononucleosis- symptoms such as malaise, persistent fever, myalgia and cervical lymphadenopathy with less common symptoms such as pneumonia and hepatitis. 3,4 It is crucial to note that the vast majority of CMV infections in pregnant women are asymptomatic. 5 Most cCMV cases present no signs or symptoms at birth. However, asymptomatic infants may develop neurodevelopmental impairments later in life. Research indicates that up to 13.5% of asymptomatic infants may experience late-onset neurodevelopmental impairments or sensorineural hearing loss (SNHL). 6,7 In contrast, symptomatic cCMV infections at birth are associated with a higher risk of severe neurodevelopmental sequelae, including intellectual disability, cerebral palsy, and profound SNHL. 8,9 Studies suggest that approximately 15%–35% of infants develop SNHL due to cCMV, 10 with bilateral hearing loss more common in symptomatic cases and unilateral hearing loss more frequently observed in asymptomatic cases. 11–13 Globally, it is estimated that cCMV affects 0.5% to 2% of newborns annually. However, the exact prevalence of cCMV in Saudi Arabia is not publicly documented. Seroprevalence studies indicate CMV seropositivity ranging from 91.2%-100% across all age groups of females tested. 14–16 cCMV infection happen due to reactivation or reinfections during pregnancy. With approximately 500,000 births annually in Saudi Arabia, 17 assuming a 1% congenital infection rate, an estimated 5,000 infants could be born with cCMV each year. This prevalence suggests a significant public health impact, potentially leading to up to 1750 cases of hearing loss annually attributable to cCMV. The importance of CMV screening for all newborns, particularly asymptomatic infants, has been underscored in research and clinical practice guidelines. 18,19 Screening facilitates early identification of infants at risk for hearing loss and other sequelae, allowing for timely intervention and management. While antiviral therapies such as ganciclovir and valganciclovir may mitigate symptoms and potentially improve outcomes in symptomatic cases, their impact remains under investigation. 20 Audiologists and speech-language pathologists (SLPs) play integral roles in multidisciplinary teams caring for children with cCMV. 21,22 Audiologists specialize in evaluating and treating individuals with hearing and balance disorders, while SLPs focus on assessment and treatment of speech, language, communication, swallowing, and voice disorders. 23 This multidisciplinary approach is crucial given the wide-rang -Abstract Truncated-
health care sciences & services